OpenDNA
The AI engine Fit Assessment
BetaOpenDNA effectively leverages machine learning for genomic data analysis, enabling personalized treatment strategies and discovering new patterns in genetic risks.
Blurb
Operator of a biotechnology company intended to offer genetically personalized medicine for chronic multi-gene diseases.
HQ Location
Israel
Founded
2018
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Genomic Data Analysis
Operator of a biotechnology company intended to offer genetically personalized medicine for chronic multi-gene diseases. The company's platform uses precision genomic AI that combines clinical and genomic data for detailed analysis of heart diseases and its prediction models help identify high-risk patients and their key prevention strategies, enabling physicians to easily prescribe the genetically fit treatment to their patients at a point of care.